HMedical ResearchEIN: 263160079· Ruling Year: 2008

Foundation For Angelman Syndrome Therapeutics

Austin, Texas

A-Health Score
83A-

Financial Health Score

9-metric score across financial health, operational efficiency, and organizational resilience. Based on IRS Form 990 data.

Very Good

💰
$6.5M
Total Revenue
📊
$23.2M
Total Expenses
🏦
$39.8M
Net Assets
📋
$18.6M
Total Liabilities

Financial Trends

5-Year Trend Analysis

Financial Health Indicators

Revenue Growth
-87.6%
Year-over-year change (2022 → 2023)
Net Margin
-256.0%
Revenue minus expenses as % of revenue
Working Capital Ratio
1.71
Net assets divided by total expenses
Liabilities-to-Assets
31.8%
Total liabilities as % of total assets

Filing History

13 filings on record
YearRevenueExpensesAssets
2023$6,525,81588%$23,229,158160%$58,430,2427%
2022$52,477,8191219%$8,933,02153%$63,075,354255%
2021$3,977,48757%$5,835,36591%$17,749,9943%
2020$9,357,65463%$3,052,39533%$18,338,53153%
2019$5,739,1839%$4,561,87955%$12,005,46935%
2018$5,274,39340%$2,948,06848%$8,901,86615%
2017$8,749,69999%$5,643,83064%$7,713,003247%
2016$4,397,320308%$3,450,740164%$2,221,53986%
2015$1,078,47329%$1,305,3878%$1,194,95924%
2014$1,528,78073%$1,208,34028%$1,571,92942%
2013$881,7024%$947,452164%$1,108,9896%
2012$922,47551%$359,02399%$1,174,73965%
2011$612,782$180,657$711,397

Frequently Asked Questions

What does Foundation For Angelman Syndrome Therapeutics do?

Foundation For Angelman Syndrome Therapeutics is a medical research nonprofit organization based in Texas. It is classified under NTEE code H12 and is registered as a 501(c) tax-exempt organization with the IRS.

Is Foundation For Angelman Syndrome Therapeutics financially healthy?

Based on our 9-metric Financial Health Score model, Foundation For Angelman Syndrome Therapeutics has a score of 83/100 (Grade: A-). This score evaluates working capital, surplus consistency, debt ratio, revenue trends, program spending, fundraising efficiency, executive compensation, revenue diversification, and vulnerability indicators.

How much revenue does Foundation For Angelman Syndrome Therapeutics generate?

Foundation For Angelman Syndrome Therapeutics reports $5.4M in annual revenue and holds $44.9M in total assets, based on IRS filings.

Similar Organizations

Explore more organizations in the Medical Research category, or browse all nonprofits in Texas.